Numinus Wellness To Acquire Mindspace Psychology Services Of Montreal

Numinus Wellness (TSXV: NUMI) is acquiring that of Mindspace Psychology Services, whom operates as Mindspace Wellbeing, a reported leader and pioneer in psychedelic programming. The quote-filled announcement was made this morning, with Numinus stating that it will enable the company to provide an evidence-based psychedelic assisted psychotherapy program to patients.

The release this morning began by outlining how the two firms were a “strong corporate and cultural fit,” and how the partners share “a vision and values,” which likely doesn’t bode well for the company actually acquiring anything of deep value.

The acquisition of Mindspace will enable Numinus to add Montreal to its areas of service, with the company reportedly having three locations within the city as well as “extensive” virtual services. The company has reportedly generated revenue of $1.7 million over the prior twelve months, which is expected to grow with the addition of ketamine-assisted therapy to the firms current offerings.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Notably, the “Corporate Wellbeing” practice of Mindspace is not included within the current acquisition agreement, which is now slated to be rebranded. The three locations that are being acquired will continue to be operated by founder Dr Joe Flanders, under the banner “Mindspace by Numinus.”

The terms of the acquisition will see Numinus pay $500,000 upon closing of the transaction, along with a time-based payout of 441,176 common shares of the company over 24 months. The company is to also pay $100,000 in Numinus shares at market price on the first three anniversaries of the closing date of the transaction, while also paying a multi-year performance payout of $800,000 in Numinus shares at market price. The timing of the final payout arrangement is unclear.

The transaction is expected to close by December 31, 2020.

Numinus Wellness last traded at $2.23 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Numinus Wellness Increases Financing To $15.0 Million

Numinus Wellness (TSXV: NUMI) has increased the size of the bought deal financing that it...

Monday, December 7, 2020, 10:46:35 AM

Numinus Wellness Sells Off Shares In Alto Neuroscience Ahead Of IPO

Numinus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in...

Thursday, February 1, 2024, 09:28:12 AM

Numinus Sells Utah Clinics For US$3.53 Million

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is...

Friday, November 15, 2024, 08:03:39 AM

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus...

Tuesday, April 12, 2022, 07:56:51 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM